세계의 아밀로이드증 치료 시장 규모, 점유율, 성장 분석 : 유형별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)
Amyloidosis Treatment Market Size, Share, and Growth Analysis, By Type (Medication, Surgery), By End-use (Hospitals & Clinics, Ambulatory Surgical Centers), By Region - Industry Forecast 2025-2032
상품코드:1681690
리서치사:SkyQuest
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
아밀로이드증 치료 시장 규모는 2023년 58억 7,000만 달러로 평가되었습니다. 또한, 2024년 63억 2,000만 달러에서 2032년에는 113억 5,000만 달러로 성장하고, 예측 기간(2025-2032) 동안 7.6%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.
세계 아밀로이드증 치료 시장은 고령화, 인식 개선, 진단율 향상, 치료 옵션의 발전으로 인해 괄목할 만한 성장세를 보이고 있습니다. 장기 기능 장애를 유발하는 아밀로이드 단백질의 축적을 특징으로 하는 아밀로이드증은 화학요법, 줄기세포 이식, 단클론 항체 및 저분자 억제제와 같은 최첨단 표적 치료와 같은 치료의 혁신을 주도하며 주목을 받고 있습니다. 이러한 새로운 접근법은 질병의 진행을 멈추거나 되돌릴 수 있는 가능성을 보여주고 있으며, 제약회사들의 연구개발에 대한 막대한 투자를 유도하고 있습니다. 치료비 상승과 환자의 예후를 개선하기 위한 조기 진단의 중요성 등의 과제에도 불구하고, 효과적인 치료법이 속속 등장하고 있어 아밀로이드증 치료 시장은 앞으로도 성장세를 유지할 것으로 보입니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
아밀로이드증 치료 시장 규모 : 유형별&CAGR(2025-2032년)
시장 개요
치료법
화학요법
표적치료
항혈관 신생 요법
단일클론항체
프로테아좀 억제제
수술
골수 이식/줄기세포 이식
장기 이식
아밀로이드증 치료 시장 규모 : 최종 용도별&CAGR(2025-2032년)
시장 개요
병원 및 클리닉
외래수술센터(ASC)
홈케어
기타
아밀로이드증 치료 시장 규모 : 지역별&CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
매출 전년대비 비교(2022-2024년)
주요 기업 개요
Alnylam Pharmaceuticals(United States)
Ionis Pharmaceuticals(United States)
Intellia Therapeutics(United States)
Genmab(Denmark)
Pfizer(United States)
BridgeBio Pharma(United States)
Eidos Therapeutics(United States)
Prothena Corporation(United States)
Alexion Pharmaceuticals(United States)
SOM Biotech(Spain)
Neurimmune(Switzerland)
Corino Therapeutics(United States)
Proclara Biosciences(United States)
Arcturus Therapeutics(United States)
Dicerna Pharmaceuticals(United States)
GlaxoSmithKline(United Kingdom)
Johnson & Johnson(United States)
Novartis(Switzerland)
Roche(Switzerland)
결론과 제안
LSH
영문 목차
영문목차
Amyloidosis Treatment Market size was valued at USD 5.87 billion in 2023 and is poised to grow from USD 6.32 billion in 2024 to USD 11.35 billion by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).
The global amyloidosis treatment market is experiencing notable growth, fueled by rising awareness, improved diagnostic rates, and advancements in therapeutic options amid an aging population. Characterized by the buildup of amyloid proteins causing organ dysfunction, amyloidosis has garnered increased attention, driving innovations in treatment, such as chemotherapy, stem cell transplantation, and cutting-edge targeted therapies like monoclonal antibodies and small molecule inhibitors. These novel approaches are demonstrating potential in halting or reversing disease progression, prompting significant investments in R&D from pharmaceutical companies. Despite challenges like high treatment costs and the critical need for early diagnosis to enhance patient outcomes, the continued emergence of effective therapies suggests that the amyloidosis treatment market will sustain its growth trajectory in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Amyloidosis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Amyloidosis Treatment Market Segments Analysis
Global Amyloidosis Treatment Market is segmented by Type, End-use and region. Based on Type, the market is segmented into Medication and Surgery. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Amyloidosis Treatment Market
The rising incidence of amyloidosis, encompassing both AL amyloidosis and ATTR amyloidosis, serves as a crucial driver for the market. Enhanced awareness and advancements in diagnostic techniques are contributing to an increase in accurate diagnoses, resulting in a larger population of patients who require effective treatment options. As more individuals are identified and confirmed as having this condition, the demand for innovative therapies and comprehensive care is expected to grow significantly, thereby propelling the amyloidosis treatment market forward. This upward trend in patient identification highlights the urgency for improved treatment solutions and fosters ongoing research and development in this field.
Restraints in the Amyloidosis Treatment Market
The amyloidosis treatment market faces significant challenges due to the limited availability of effective treatment options, despite ongoing advancements in research and drug development. Many individuals diagnosed with amyloidosis experience inadequate responses to existing therapies, highlighting the urgent need for more effective solutions. This situation not only hampers patient outcomes but also creates a pressing demand for innovative treatments that can address the unique complexities of the disease. As a result, the market is restrained by the necessity for enhanced therapeutic options that can better meet the needs of patients struggling with this challenging condition.
Market Trends of the Amyloidosis Treatment Market
The amyloidosis treatment market is witnessing a significant shift towards advancements in targeted therapies, driven by intensive research and development. Pharmaceutical companies are increasingly focusing on monoclonal antibodies and small molecules, which aim to inhibit the production and deposition of amyloid proteins characteristic of the disease. This innovative approach seeks to enhance patient outcomes by directly addressing the underlying pathophysiology. Ongoing clinical trials are crucial in evaluating the safety and efficacy of these novel treatments, indicating a promising future for therapeutic options. As these therapies progress towards approval, they are expected to fundamentally redefine the treatment landscape for amyloidosis, creating lucrative opportunities within the market.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Amyloidosis Treatment Market Size by Type & CAGR (2025-2032)
Market Overview
Medication
Chemotherapy
Targeted therapy
Anti-Angiogenesis Therapy
Monoclonal Antibodies
Proteasome Inhibitors
Surgery
Bone Marrow Transplantation/Stem Cell Transplantation
Organ Transplantation
Global Amyloidosis Treatment Market Size by End-use & CAGR (2025-2032)
Market Overview
Hospitals & Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
Global Amyloidosis Treatment Market Size & CAGR (2025-2032)
